CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $271,000 | +47.3% | 54,239 | +272.2% | 0.02% | +31.6% |
| Q4 2020 | $184,000 | +17.9% | 14,574 | -17.3% | 0.02% | +72.7% |
| Q1 2020 | $156,000 | +13.0% | 17,631 | +52.9% | 0.01% | -8.3% |
| Q2 2019 | $138,000 | -28.1% | 11,534 | -27.3% | 0.01% | -14.3% |
| Q1 2019 | $192,000 | -16.2% | 15,868 | -28.8% | 0.01% | -61.1% |
| Q4 2016 | $229,000 | -66.2% | 22,288 | -55.0% | 0.04% | -54.4% |
| Q1 2016 | $677,000 | +48.1% | 49,568 | +105.8% | 0.08% | +97.5% |
| Q4 2015 | $457,000 | – | 24,080 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |